Effect of formulation parameters on corneal permeability of ofloxacin

Scientia Pharmaceutica

Volumn 76, Issue 3, 2008, Pages 505-514

  Ahuja, Munish ^a   Singh, Gurmeet ^a   Majumdar, Dipak K ^b  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Corneal permeation; Formulation factors; Ofloxacin; Papp

Indexed keywords

BENZALKONIUM CHLORIDE; BENZYL ALCOHOL; BUFFER; EDETIC ACID; EYE DROPS; METHYL PARABEN; METHYLCELLULOSE; OFLOXACIN; PHENYLMERCURIC ACETATE; POLYVINYL ALCOHOL; PRESERVATIVE; PROPYL PARABEN; THIOMERSAL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA PERMEABILITY; DRUG FORMULARY; DRUG FORMULATION; DRUG PENETRATION; GOAT; NONHUMAN; VISCOSITY;

EID: 52449102221     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0804-22     Document Type: Article

References (22)

1. Hardman JG, Limbird LE. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 2001.
2. Adenis JP, Colin J, Verin P, Saint-Blancat P, Malet F. Ciprofolxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis. Eur J Ophthalmol. 1995; 5: 82-87.
3. The United States Pharmacopoeia. United States Pharmacopoeial Convention, Inc, Rockville, 2005: 1413-1414.
4. Donnenfield ED, Schrier A, Perry HD, Aulicino T, Gombert ME, Snyder R. Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor. Ophthalmology. 1994; 101: 902-905.
5. Borman L, Tang-liu D, Kann J, Nista J, Lin ET, Frank J. Ofloxacin in human serum, urine and tear film following topical application. Cornea. 1992; 11:226-230.
6. Aoki K, Moroboski ST. Clinical effect of ofloxacin ointment for chlamydial conjunctivitis. Jap J Clin Ophthalmol.1986; 40: 985-988.
7. Di Colo G, Zambito Y, Burgalassi S, Nardini I, Saettono MF. Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin. Int J Pharm. 2004; 273: 37-44. [doi:10.1016/j.ijpharm.2003. 12.018]
8. Di Colo G, Burgalassi S, Zambito Y, Monti D, Chetoni P. Effects of different N-trimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation. J Pharm Sci. 2004; 93: 2851-2862. [doi:10.1002/jps.20197]
9. Smolen VF, Bull L, editors. The Control of Drug Bioavailability from Ophthalmic Dosage Forms. In: Bioavailability Control by Drug Delivery System Design.Volume 3.
10. Malhotra M, Majumdar DK. Permeation through cornea. Indian J Exp Biol. 2001; 39: 11-24.
11. Rojanasakul Y, Robinson JR. Transport mechanisms of the cornea: characterization of barrier permselectivity. Int J Pharm. 1989; 55: 237-246. [doi:10.1016/0378-5173(89)90047-1]
12. Kawazu K, Midori Y, Shiono H, Ota A. Characterisation of the carrier-mediated transport of levofloxacin, a fluoroquinolone antimicrobial agent, in rabbit cornea. J Pharm Pharmacol. 1999; 51: 797-801. [doi:10.1211/0022357991773168]
13. Usayapant A, Karara AH, Narukar MM. Effect of 2-hydroxypropyl-β- cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate. Pharm Res. 1981; 12: 1495-1499.
14. Davies NM, Wavy G, Tucker IG. Evaluation of hydrocortisone/hydroxypropyl - β-cyclodextrin solution for ocular drug delivery. Int J Pharm. 1997; 56: 201-209. [doi:10.1016/S0378-5173(97)00199-3]
15. Sasaki H, Tei C, Yamamura K, Nishida K, Namammura J. Effect of preservatives on systematic delivery of Insulin by ocular instillation in rabbits. J Pharm Pharmacol. 1994; 46: 871-875.
16. Ahuja M, Dhake AS, Majumdar DK. Effect of formulation factors on in vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea. Yakugaku Zasshi. 2006; 126: 1369-1375. [doi:10.1248/yakushi. 126.1369]
17. Fu RC, Lidgate DM. In vitro rabbit corneal permeability study of ketorolac tromethamine, a non steroidal anti-inflammatory agent. Drug Dev Ind Pharm. 1986; 12: 2403-2430.
18. Pawar PK, Majumdar DK. Effect of formulation parameters on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep and buffalo corneas. AAPS PharmSciTech. 2006; 7: E12-E17. [doi:10.1208/pt070113]
19. Rathore MS, Majumdar DK. Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS PharmSciTech. 2006; 7: E89-E94. [doi:10.1208/pt070357]
20. Tiefenbacher EM, Haen E, Pryzbilla B, Kurz H. Photodegradation of some quinolones used as antimicrobial therapeutics. J Pharm Sci.1994; 83: 463-467. [doi:10.1002/jps.2600830403]
21. Grass GM, Wood RW, Robinson JR. Effects of calcium chelating agents on corneal permeability. Invest Ophthalmol Vis Sci. 1985; 26: 110-113.
22. Malhotra M, Majumdar DK. Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine. Indian J Exp Biol. 2002; 40: 555-559.